{
 "PrintNo":"A9580","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2022-03-16T14:30:54.736206Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-03-16","Committee":"Insurance"}],
 "Actions":[{"Text":"REFERRED TO INSURANCE","Date":"2022-03-16","Chamber":"ASSEMBLY"}],
 "Sponsors":[{"ID":520,"Name":"Linda Rosenthal","Short":"ROSENTHAL L"}],
 "Title":"Prohibits the preferred drug program, managed care programs and insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs prescribed to a person for HIV or AIDS",
 "Summary":"Prohibits the preferred drug program, managed care programs and insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs prescribed to a person for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS).",
 "LawSection":"Public Health Law",
 "LawCode":"Amd §273, Pub Health L; amd §364-j, Soc Serv L; amd §§3216, 3221 & 4303, Ins L",
 "ActClause":"AN ACT to amend the public health law, in relation to prohibiting the preferred drug program from restricting or imposing delays in the distribution of antiretroviral prescription drugs to certain persons; to amend the social services law, in relation to prohibiting managed care programs from restricting or imposing delays in the distribution of antiretroviral prescription drugs to certain persons; and to amend the insurance law, in relation to prohibiting insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs to certain persons",
 "SameAsPrintNo":"S8423-2021"
}